Axion BioSystems buys live-cell imaging analyser

Live-cell assay systems specialist Axion BioSystems of Atlanta, Georgia has purchased Netherlands-based CytoSMART Technologies for its kinetic live-cell imaging analysis. Terms were not disclosed. The acquisition aims to boost Axion’s expansion into stem cell research, immuno-oncology cell-based therapies and drug discovery.

Non-invasively studying the real-time biology of live cells allows scientists to obtain a more complete understanding of the complex processes underpinning health and disease. Axion and CytoSMART have focused on the development of next-generation analysis tools for use in pharmaceutical, academic and biotechnology research.

The takeover follows Axion’s recent purchase of UK-based printed electronics manufacturer M-Solv Manufacturing.

Tom O’Brien, President & CEO of Axion BioSystems, said: “Since Axion BioSystems’ inception, our focus has been on developing user-centric products that accelerate scientific discovery, with the specific goal of building innovative systems that monitor cellular activity without disturbing the underlying biology.”

O’Brien claims The Maestro, Axion’s flagship bioelectronic assay (BEA) platform, has transformed neurological disease research over the past 14 years.